Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
296.41
+4.68 (1.60%)
At close: May 15, 2025, 4:00 PM
290.84
-5.57 (-1.88%)
After-hours: May 15, 2025, 5:36 PM EDT
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $8.52 billion as of May 15, 2025. Its market cap has decreased by -31.30% in one year.
Market Cap
8.52B
Enterprise Value
8.23B
1-Year Change
-31.30%
Ranking
Category
Stock Price
$296.41
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $8.52B, an increase of 673.29%. That is a compound annual growth rate of 26.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 8.38B | -18.80% |
| Dec 31, 2024 | 10.33B | 9.79% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |